FDA Drug Application (020254) for VOLTAREN-XR by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020254
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage100MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameVOLTAREN-XR
Active IngredientDICLOFENAC SODIUM

Active IngredientCount
List of drugs with Active Ingredient DICLOFENAC SODIUM8


Back to FDA Applications sponsored by NOVARTIS